Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors
Document Type
Journal Article
Publication Date
2-6-2025
Journal
medRxiv : the preprint server for health sciences
DOI
10.1101/2025.02.04.25321499
Keywords
Pediatric brain tumors; aberrant splicing; loss of heterozygosity; pathogenic germline variants
Abstract
The contribution of rare pathogenic/likely pathogenic (P/LP) germline variants to pediatric central nervous system (CNS) tumor development remains understudied. Here, we characterized the prevalence and clinical significance of germline P/LP variants in cancer predisposition genes across 830 CNS tumor patients from the Pediatric Brain Tumor Atlas (PBTA). We identified germline P/LP variants in 24.2% (201/830) of patients and the majority (154/201) lacked clinical reporting of genetic tumor syndromes. Among P/LP carriers, 30.7% had putative somatic second hits or loss of function tumor alterations. Finally, we linked pathogenic germline variation with novel somatic events and patient survival to highlight the impact of germline variation on tumorigenesis and patient outcomes.
APA Citation
Corbett, Ryan J.; Kaufman, Rebecca S.; McQuaid, Shelly W.; Vaksman, Zalman; Phul, Saksham; Brown, Miguel A.; Mason, Jennifer L.; Waszak, Sebastian M.; Zhang, Bo; Zhong, Chuwei; Desai, Heena; Hausler, Ryan; Naqvi, Ammar S.; Chroni, Antonia; Geng, Zhuangzhuang; Gonzalez, Elizabeth M.; Zhu, Yuankun; Heath, Allison P.; and Li, Marilyn, "Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors" (2025). GW Authored Works. Paper 6615.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/6615
Department
Pediatrics